Jian-Jin Tang et al's study of coronary artery disease (CAD) patients indicated that GSTM1 genotype have no effect on plasma GSH levels, and the deletion of GSTTT1 increased the plasma GSH levels in the CAD patients [36]. This evidence concerns the gene GSTM1 and coronary artery disorder.